medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2025, Number 1

<< Back Next >>

Rev Latin Infect Pediatr 2025; 38 (1)

Sphingomonas paucimobilis as a cause of community-acquired urinary tract infection in pediatrics?

Siegert OAI, Soltero BDC, Cisneros CPA, Reyes MIJ, Pérez MJR, González VKY, Morales PCT

Language: Spanish
References: 10
Page: 32-35
PDF size: 258.44 Kb.


ABSTRACT

Sphingomonas paucimobilis infections are rare, even more in children. It can cause infection in any organ. The infection can be acquired in nature or in the hospital setting. The course of the infection is mostly benign, with mortality being rare. In this paper we describe the fourth case worldwide, and the first in the American continent of urinary tract infection in pediatric patients due to S. paucimobilis. The case described is a six-year-old male who arrived at the pediatric emergency room with nausea, vomiting, and abdominal pain. On physical examination he was found to has low blood pressure. Empirical treatment with ceftriaxone was started after taking cultures, with good evolution. The report of the urine culture taken with a bladder catheter reported growth greater than 50,000 CFU of multisensitive S. paucimobilis. He was discharged on cefixime, and at the time of this writing he has been healthy on follow-up.


REFERENCES

  1. Ionescu MI, Neagoe DS, Craciun AM, Moldovan OT. The Gram-negative bacilli isolated from caves-Sphingomonas paucimobilis and Hafnia alvei and a review of their involvement in human infections. Int J Environ Res Public Health. 2022; 19 (4): 2324. doi: 10.3390/ijerph19042324.

  2. Muhyi A, Aswin A. Sphingomonas paucimobilis an unusual cause of subdural empyema in pediatric: a case report. PedScij. 2021; 2 (1): 1-3. doi: 10.51559/pedscij.v2i1.19.

  3. Aleksejeva V, Dovbenko A, Kroica J, Skadins I. Toys in the playrooms of children's hospitals: a potential source of nosocomial bacterial infections? Children (Basel). 2021; 8 (10): 914. doi: 10.3390/children8100914.

  4. Bayram N, Devrim I, Apa H, Gülfidan G, Türkyilmaz HN, Günay I. Sphingomonas paucimobilis infections in children: 24 case reports. Mediterr J Hematol Infect Dis. 2013; 5 (1): e2013040. doi: 10.4084/MJHID.2013.040.

  5. Askin FN, Erinmez M, Oren AC, Manay AB, Zer Y. Sphingomonas paucimobilis outbreak a pediatric hematology-oncology hospital: epidemiological investigation and literature review of an emerging healthcare-associated infection. Jpn J Infect Dis. 2022; 75 (4): 374-381. doi: 10.7883/yoken.JJID.2021.661.

  6. Hardjo-Lugito NP, Cucunawangsih, Kurniawan A. A lethal case of Sphingomonas paucimobilis bacteremia in an immunocompromised Patient. Case Rep Infect Dis. 2016;2016:3294639. doi: 10.1155/2016/3294639.

  7. Laupland KB, Paterson DL, Stewart AG, Edwards F, Harris PNA. Sphingomonas paucimobilis bloodstream infection is a predominantly community-onset disease with significant lethality. Int J Infect Dis. 2022; 119: 172-177. doi: 10.1016/j.ijid.2022.03.060.

  8. Lin JN, Lai CH, Chen YH, Lin HL, Huang CK, Chen WF et al. Sphingomonas paucimobilis bacteremia in humans: 16 case reports and a literature review. J Microbiol Immunol Infect. 2010; 43 (1): 35-42. doi: 10.1016/S1684-1182(10)60005-9.

  9. Benevides GN, Hein N, Lo DS, Ferronato AE, Ragazzi SLB, Yoshioka CRM et al. Otomastoiditis caused by Sphingomonas paucimobilis: case report and literature review. Autopsy Case Rep. 2014; 4 (3): 13-20. doi: 10.4322/acr.2014.024.

  10. Demiray T, Koroglu M, Ozbek A, Altindis M. Detection and clinical implications of biofilm formation among clinical isolates of Sphingomonas paucimobilis in Turkey. Jundishapur J Microbiol. 2017; 10 (1): e35924. doi: 10.5812/jjm.359244.




2020     |     www.medigraphic.com